Diferencia entre revisiones de «Anticoagulants»
Sin resumen de edición |
Sin resumen de edición |
||
| Línea 28: | Línea 28: | ||
*[[Anticoagulant reversal for life-threatening bleeds]] | *[[Anticoagulant reversal for life-threatening bleeds]] | ||
*[[Antiplatelet medications]] | *[[Antiplatelet medications]] | ||
[[Category:Pharmacology]] | |||
Revisión del 22:38 13 nov 2016
Vitamin K Antagonist
Blocks activation of vitamin K dependent prothrombotic factors II, VII, IX, X and blocks synthesis of vitamin K dependent ANTI-thrombotic proteins C and S
Heparins
Bind to and activate antithrombin, which in turns inactivates factor Xa and thrombin
Factor Xa Inhibitors
Inhibits Factor Xa, leading to inactivation of thrombin
- Rivaroxaban (Xarelto)
- Apixaban (Eliquis)
- Fondaparinux
- Edoxaban
Direct Thrombin Inhibitors
Self-explanatory
